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We examined the interaction of Abelson murine leukemia virus protein P120
with other cellular components after extraction with the nonionic detergent
Triton X-100. Most of the Abelson murine leukemia virus P120-associated kinase
activity was found in the detergent-insoluble matrix in both lymphoid and
fibroblast cell lines. The P120 labeled during a short exposure of cells to [35S]-
methionine was mainly in the detergent-insoluble matrix (lymphoid cells) or
equally distributed in the detergent-insoluble matrix and the soluble fraction
(fibroblasts). Steady-state-labeled P120 was distributed equally in the two frac-
tions (lymphoid cells) or mostly in the soluble portion (fibroblasts). Thus, there
was an apparent movement of P120 from the detergent-insoluble matrix to the
detergent-soluble fraction and a concomitant loss of enzymatic activity. When
the detergent-insoluble matrix was incubated with [32P]ATP in situ, phosphoryl-
ation of tyrosine residues of P120 was observed. We found an 80,000-molecular-
weight fragment of P120 (designated F80) after extraction of fibroblast cells with
detergent. F80 was not found in extracted lymphoid cells, but mixing labeled
lymphoid cells and unlabeled fibroblasts before extraction produced the fragment.
F80 contained the gag determinants of P120 but did not react with Abelson-
specific serum. These data allowed us to assign various features of the protein to
regions of the P120 molecule and to localize the Abelson-specific antigenic
determinants to the C-terminal region of the molecule.
Abelson murine leukemia virus (A-MuLV) is
a replication-defective, rapidly transforming
retrovirus. It can induce leukemia in vivo (1)
and transform bone marrow cells and some es-
tablished mouse cell lines in vitro (16, 18, 23),
and a number of A-MuLV strains have been
identified (7a, 17). The sole A-MuLV-encoded
product is a protein consisting of the amino-
terminal 30,000 daltons of the Moloney murine
leukemia virus (M-MuLV) gag gene precursor
attached to the carboxy-terminal region of a
polypeptide encoded by a mouse gene (28; S. P.
Goff, R. Lee, and D. Baltimore, unpublished
data). This protein is responsible for transfor-
mation of cells by A-MuLV (28; S. P. Goff and
D. Baltimore, unpublished data). A-MuLV pro-
teins have molecular weights ranging from
160,000 to 90,000; the prototype A-MuLV strain
encodes a 120,000-molecular-weight protein des-
ignated P120. P120 is a phosphorylated surface
membrane protein which becomes labeled with
32p on tyrosine residues when it is incubated
t Present address: Department of Biochemistry and Molec-
ular and Cellular Biology, Northwestern University, Evanston,
IL 60201.
with [3P]ATP after immunoprecipitation (25).
This behavior is similar to the protein kinase
activities associated with proteins encoded by
certain other transforming viruses, notably
pp6Osrc of Rous sarcoma virus (6, 8) and the
proteins of Fujinami sarcoma virus (7), Y73 (9),
PRC II (13), and feline sarcoma virus (24).
Detergent extraction of intact cells yields in-
soluble residues which retain the major morpho-
logical features of the cells from which they were
derived (2). This extraction procedure opera-
tionally defines the following two fractions: a
soluble fraction (designated SOL) and a deter-
gent-insoluble subcellular matrix (designated
DIM), commonly referred to as the cytoskeleton
(2, 4, 22). In this work we studied the interaction
of P120 with other cellular components after
extraction with the nonionic detergent Triton
X-100. Although numerous cell types have been
extracted with Triton X-100 (2, 3, 12, 22), the
insoluble matrix has been best characterized
from human erythrocytes, where it has been
demonstrated that only the cytoskeleton and
linked components remain after extraction (19,
20, 29).
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Recently, it has been shown that pp608rc iS
associated with the DIM fraction of Rous sar-
coma virus-infected chicken embryo fibroblasts
after Triton X-100 extraction (3). In this paper
we show that most of the A-MuLV P120-asso-
ciated kinase activity is found in the DIM frac-
tion in both lymphoid and fibroblast cell lines.
However, studies of the distribution of ['S]me-
thionine and in vivo 'PO4-labeled protein re-
vealed a more complex pattem. When the DIM
fraction was incubated with [32P]ATP in situ,
phosphorylation of the tyrosine residues of P120
occurred. This fractionation procedure has
helped to localize the functional regions of the
P120 molecule and proteins derived from it.
MATERIALS AND METHODS
Cell lines. The A-MuLV-transformed fibroblast
cell lines which we used were as follows: ANN-1, an
A-MuLV(P120)-transformed NIH/3T3 nonproducer
cell line (18); A2, an A-MuLV(P120)-transformed
NIH/3T3 nonproducer cell line that makes both a
P120 protein and a P90 protein; P160N54, an A-
MuLV(P160)-transformed NIH/3T3 nonproducer cell
line; P90B-3, an A-MuLV(P90)-transformed NIH/3T3
cell line; and P92td, an NIH/3T3 cell line nonproduc-
tively infected with the transfurmation-defective A-
MuLV strain A-MuLV(P92td) (17, 26). The A-MuLV-
transformed lymphoid cell lines used were as follows:
2M3, a P120 nonproducer cell line; an M-MuLV-su-
perinfected derivative of 2M3, 2M3/M (28); 18-81, a
P120 producer cell line; and 18-48, a P100 producer
cell line (21). We also used 70Z, a BALB/c-derived,
chemically transformed, pre-B-lymphoid cell line (14).
Lymphoid cells were grown in RPMI 1640 medium
containing 10% calf serum and 5 x 10' M O-mercap-
toethanol. Other lines were grown in Dulbecco modi-
fied Eagle medium containing 10% calf serum.
linmune sera. Goat anti-M-MuLV serum and anti-
Moloney gag-specific sera were provided by the Di-
vision of Cancer Cause and Prevention, National Can-
cer Institute, Bethesda, Md. Anti-AbT serum contain-
ing antibodies that immunoprecipitated A-MuLV pro-
teins by virtue of their non-gag determinants has been
described previously (27). Rebbit anti-vimentin was a
gift from Richard Hynes, Massachusetts Institute of
Technology.
Cell labeling. Radioactive chemicals were pur-
chased from New England Nuclear Corp., Boston,
Mass. Cells were washed with phosphate-buffered sa-
line and incubated in labeling medium.
When labeled with [3S]methiouine, cells were in-
cubated in Dulbecco modified Eagle medium lacking
unlabeled methionine but supplemented with 2% di-
alyzed fetal calf serum and 125 ,uCi of [3S]methionine
per ml for 1 to 2 h. For overnight labeling under
nonlimiting conditions, [3S]methionine was added to
whole Dulbecco modified Eagle medium. When la-
beled with 'PO4, cells were incubated in Dulbecco
modified Eagle medium lacking unlabeled P04 but
supplemented with 2% fetal calf serum and 375 to
1,000 gUCi of 'PO4 per ml for 2 to 6 h.
Triton X-100 extraction. Usually, Triton X-100
extraction was carried out on monolayer cells in 3.5-
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cm dishes, although occasionally extraction was per-
formed on cells in suspension. Adherent cells were
allowed to attach overnight. Nonadherent cells were
allowed to settle for 1 to 2 h onto dishes coated with
poly-L-lysine (type V; Sigma Chemical Co., St. Louis,
Mo.) to induce attachment. Dishes were coated by
incubating them with 1 ml of 0.1% poly-L-lysine for 45
min at room temperature, followed by one distilled
water rinse and the addition of the cell suspension in
Dulbecco modified Eagle medium containing 2% calf
serum. For extractions, dishes were washed twice with
phosphate-buffered saline containing MgC12 and CaCl2
at 4°C. The cells were then incubated at 4°C for 2 min
with 400 p1 of extraction buffer (10 mM PIPES [1,4-
piperazinediethanesulfonic acid], pH 6.8, 100 mM KCl,
300 mM sucrose, 2.5 mM MgCl2) containing 1 mM
phenylmethylsulfonyl fluoride (Sigma), 1% aprotinin
(Sigma), and 0.5% Triton X-100. The SOL fraction
was removed, and 400 pl of extraction buffer was added
to the DIM fraction. The two fractions were solubi-
lized either in gel sample buffer for direct application
to a polyacrylamide gel or in lysis buffer (10 mM
NaHPO4-Na2HPO4, pH 7.5, 100 mM NaCl, 1% Triton
X-100, 0.5% sodium deoxycholate, 0.1% sodium dode-
cyl sulfate, 1 mM phenylmethylsulfonyl fluoride) for
clarification by centrifugation at 150,000 x g for 2 h
and subsequent immunoprecipitation. Fractions were
immunoprecipitated with 5 to 10 pi of normal or im-
mune serum. The immune complexes were isolated by
binding to Staphylococcus aureus. Sodium dodecyl
sulfate-polyacrylamide gel electrophoresis was per-
formed by using the discontinuous stacking system of
Laemmli (10). To prepare nuclei, 10mM Tris (pH 7.4),
10 mM NaCl, 25 mM MgCl2, and 0.5% Triton X-100
were added to the DIM fractions. The DIM fractions
were scraped off the' dishes and homogenized with
0.5% sodium deoxycholate and 1% Tween 40. The
nuclei were isolated by low-speed centrifugation.
In vitro and in situ kinase assays. We measured
the kinase activities of samples after immunoprecipi-
tation by incubating the isolated immune complexes
at 30°C for 9 min in 20 mM Tris (pH 8.0)-10 mM
MnCl2 containing 1 ,uCi of [nP]ATP.
In situ kinase assays of DIM fractions were per-
formed by incubating the preparations with 200 pl of
extraction buffer containing 50 ACi of [nP]ATP (spe-
cific activity, 7,000 Ci/mmol) for 2 min on ice. The
DIM fractions were then treated as described above.
High-voltage electrophoresis of phosphory-
lated amino acids. After immunoprecipitation, phos-
phorylated proteins were precipitated with trichloro-
acetic acid and washed in absolute alcohol. About
5,000 cpm of phosphate-labeled protein was hydro-
lyzed for 2 h in 6 N HCI at 100°C. Hydrolyzed samples
were suspended in 5 pl of a solution containing unla-
beled phosphoserine, phosphothreonine, and phos-
photyrosine (concentration, 1 ug/ml each). Samples
were analyzed by high-voltage electrophoresis in pyr-
idine acetic acid (pH 3.5) on Whatman 3MM paper at
2,400 V for 1 h (25).
RESULTS
To determine whether the A-MuLV-encoded
protein and its associated kinase activity were
associated with the DIM fraction or the SOL
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fraction, we have studied the following two A-
MuLV-transformed cell lines: 2M3, a lymphoid,
nonproducer cell line (28), and ANN-1, a fibro-
blast nonproducer cell line (18). The cells were
extracted with a buffer containing Triton X-100,
which was developed previously to optimize
preservation of cytoskeletal elements and reten-
tion of polyribosomes (4). Because A-MuLV-
transformed fibroblasts and lymphoid cells do
not adhere tightly to plastic, the cells were
plated onto dishes coated with poly-L-lysine,
which allowed the cells to form monolayers.
Cell fractionation. To examine the efficacy
of the extraction, ANN-1 and 2M3 cells were
labeled overnight with [35S]methionine and
treated with extraction buffer to produce the
DIM and SOL fractions. About 60% of the alkali-
resistant (0.33 N NaOH, 370C, 15 min), trichlo-
roacetic acid-precipitable, [35S]methionine-la-
beled protein was recovered in the SOL fraction.
The radioactivity remaining with the DIM frac-
tion was distributed 25% in the cytoskeletal ma-
trix and 15% in the nuclear fraction. Electropho-
retic fractionation revealed a complex spectrum
of proteins in both the DIM fraction and the
SOL fraction (Fig. 1, lanes 1 and 2); some bands
were unique to each fraction (Fig. 1, arrows),
and the fractions had numerous bands in com-
mon.
To determine more exactly the purity of the
fractions, labeled cells were extracted, and vi-
mentin distribution was assessed by immunopre-
cipitation. Vimentin is an intermediate filament
protein (11) that should be mainly in the DIM
fraction. In fibroblasts the vimentin was re-
covered almost entirely in the DIM fraction (Fig.
1, lanes 9 and 10), and in lymphoid cells a
significant amount of vimentin was recovered in
the SOL fraction (Fig. 1, lanes 5 and 6). The
specificity of immunoprecipitation was shown
by the absence or low level of vimentin in frac-
tions treated with normal rabbit serum (Fig. 1,
lanes 3, 4, 7, and 8). We are not aware that
vimentin has been identified previously in
lymphoid cells (11), and thus it is not clear
whether the extraction method which we used
released some cytoskeletal elements from
lymphoid cells or whether there was a normal
pool of soluble vimentin in such cells. Light
microscopy observations of the extracted mono-
layers showed that the overall morphology of
the cells was maintained (2, 4; data not shown).
We concluded from these experiments that the
fractionation of transformed fibroblasts held to
dishes with poly-L-lysine was effective in distin-
guishing the DIM and SOL fractions; the defi-
nition of the lymphoid cell fractions was less
certain, with a possibility of loss of some cyto-
skeletal elements from the DIM fraction.
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FIG. 1. Specificity of the fractionation procedure.
ANN-1, 2M3, and P9OB-3 cells were labeled with
[3S]methionine overnight in complete medium; this
was followed by fractionation into DIM and SOL
fractions after attachment to dishes coated withpoly-
L-lysine. Samples containing equal cell number
equivalents were analyzed with or without specific
immunoprecipitation by electrophoretic separation
and autoradiography. Samples from ANN-1 cells
were analyzed without immunoprecipitation from the
DIM fraction (lane 1) and the SOL fraction (lane 2).
Some bands unique to each fraction are indicated by
arrows. Lanes 3 and 7, DIM fractions from lines 2M3
and P9OB-3, respectively, immunoprecipitated with
normal rabbit serum; lanes 4 and 8, SOL fractions
from lines 2M3 and P9OB-3, respectively, immunopre-
cipitated with normal rabbit serum; lanes 5 and 9,
DIM fractions from lines 2M3 and P9OB-3, respec-
tively, immunoprecipitated with rabbit anti-vimentin
serum; lanes 6 and 10, SOL fractions from lines 2M3
and P9OB-3, respectively, immunoprecipitated with
rabbit anti-vimentin serum. The positions of unla-
beled marker proteins of known molecular weights
(x 103) are indicated on the right.
P120-associated kinase activity in the
DIM fraction. To examine the subcellular lo-
calization of the A-MuLV P120-associated pro-
tein kinase activity, both SOL fractions and
DIM fractions were assayed for kinase activity
after immunoprecipitation. With ANN-1 cells,
the DIM fraction contained two prominent pro-
tein bands that became phosphorylated when an
anti-M-MuLV serum precipitate was incubated
with [_y-32P]ATP (Fig. 2, lane 2). One band had
a molecular weight of 120,000 and thus was the
P120 which becomes labeled by 32pO4 on a ty-
rosine residue under these conditions (25). The
other band had a molecular weight of 75,000 to
80,000; this band was designated F80 (fragment
of about 80,000 molecular weight) and is dis-
cussed further below. The only other significant
J. VIROL.
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FIG. 2. In vitro protein kinase assay after fraction-
ation. ANN-I and 2M3 cells were fractionated into
DIM and SOL fractions after attachment to dishes
coated with poly-L-lysine. Each fraction was solubi-
lized in lysis buffer and clarified by ultracentrifuga-
tion. After immunoprecipitation and isolation of the
immune complexes with S. aureus, samples were in-
cubated in 20 mM Tris (pH 8.0)-10 mM MnCI2 con-
taining 1 ,uCi of [y-32P]ATP for 9 min at 30°C. The
products were analyzed by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis. Lanes 1 and 5,
DIM fractions from ANN-I and 2M3 cells, respec-
tively, immunoprecipitated with normal goat serum;
lanes 3 and 6, SOL fractions from ANN-1 and 2M3
cells, respectively, immunoprecipitated with normal
goat serum; lanes 2 and 7, DIM fractions from ANN-
1 and 2M3 cells, respectively, immunoprecipitated
with goat anti-M-MuLV serum; lanes 4 and 8, SOL
fractions from ANN-1 and 2M3 cells, respectively,
immunoprecipitated with goat anti-M-MuLV serum.
The positions of molecular weight markers (x 103)
are indicated on the right.
band (a band having a low molecular weight)
was also evident when normal serum was used
(Fig. 2, lane 1). The SOL fraction showed a weak
band of labeled P120 after incubation with [-y-
32P]ATP, along with a small amount of F80 (Fig.
2, lane 4). Both the SOL fraction and the DIM
fraction had a number of other weaker specific
bands that have yet to be characterized. Precip-
itation of 2M3 cell extracts followed by labeling
with [y-32P]ATP produced a dark P120 band
which was recovered exclusively in the DIM
fraction (Fig. 2, lanes 5 through 8).
The labeling of P120 and F80 in extracts of A-
MuLV-transformed cells was specific to such
cells. For instance, when 70Z cells were ex-
tracted, no phosphorylatable P120 or F80 was
detected (data not shown); 70Z cells are very
similar in their differentiated state to 2M3 cells,
but they are not transformed by A-MuLV (14).
Also, fibroblasts transformed by other agents or
untransformed fibroblasts produced no labeled
P120 and F80 bands. The lack of kinase activity
in the SOL fraction was not due to inhibitors;
when partially purified P120 was added to each
fraction, it was as effectively phosphorylated
after immunoprecipitation from the SOL frac-
tion as after immunoprecipitation from the DIM
fraction (data not shown). As an additional con-
trol, both ANN-1 and 2M3 cells were extracted
in suspension rather than bound to dishes with
poly-L-lysine and the same localization to the
DIM fraction was observed.
The distribution of P120 in ANN-1 cells, as
determined by [3S]methionine labeling, did not
follow the distribution of enzymatic activity.
After a 1-h pulse of [3S]methionine or "PO4,
the distribution of P120 was about equal in the
SOL and DIM fractions (data not shown). After
overnight steady-state labeling with [3S]methi-
onine, most of the P120 was found in the SOL
fraction, whereas a majority of the F80 protein
was found in the DIM fraction (Fig. 3, lanes 1
through 4). In 2M3 cells, after 2 h of labeling,
the [3S]methionine-labeled P120 profile was
very similar to the enzymatic distribution; most
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FIG. 3. Distribution of [3Sl]methionine-labeled
P120. ANN-I and 2M3 cells were labeled with [3S]-
methionine overnight in complete medium; this was
followed by fractionation into DIM and SOL frac-
tions, and preparations were immunoprecipitated as
described in the legend to Fig. 1. Lane 1, DIMfraction
from ANN-I cells immunoprecipitated with normal
goat serum; lane 2, SOL fraction from ANN-I cells
immunoprecipitated with normal goat serum; lanes
3 and 5, DIM fractions from ANN-I and 2M3 cells,
respectively, immunoprecipitated with goat anti-M-
MuLV serum; lanes 4 and 6, SOL fractions from
ANN-I and 2M3 cells, respectively, immunoprecipi-
tated with goat anti-M-MuLV serum.
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of the P120 was found in the DIM fraction (data
not shown). After ovemight labeling of2M3 cells
with [3S]methionine, a significant proportion of
the P120 was found in the SOL fraction (Fig. 3,
lanes 5 and 6).
Origin of F80. The labeled F80 in ANN-1
extracts might have been either a protease diges-
tion product of P120 or a kinase substrate. To
distinguish between these two possibilities, we
performed partial protease digestion on the two
proteins (5), and the electrophoretic similarity
of these digests suggested that P120 and F80
were related (data not shown). Immunoprecipi-
tation with sera specific for individual gag pro-
teins showed that when P120 was immunopre-
cipitated, so was F80 (Fig. 4, lanes 1 through 5).
This was not a consequence of a P120-F80 com-
plex because serum specific for non-gag deter-
minants on P.20 (anti-AbT serum [27]) immu-
noprecipitated P120 but not F80 (Fig. 4, lane 7),
whereas normal mouse serum precipitated nei-
ther protein (Fig. 4, lane 6). The immunoprecip-
itation data implied that F80 contains the gag
determinants ofP120 but lacks the determinants
recognized by at least anti-AbT serum.
To investigate whether there might be a pre-
-8 0 -
FIG. 4. Antigenic relationship between P120 and
F80. ANN-I cells were pulsed for 1 h with [3S]me-
thionine, and the unfractionated cells were extracted
and immunoprecipitated as described in the legend
to Fig. 1 with the following sera: normal goat serum
(lane 1), anti-plO serum (lane 2), anti-p30 serum (lane
3), anti-p12 serum (lane 4), anti-reverse transcrip-
tase/p15 serum (lane 5), normal mouse serum (lane
6), and anti-AbT serum (lane 7).
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cursor-product relationship between P120 and
F80, ANN-1 cells were labeled with [3S]methi-
onine for periods between 10 min and 2 h and
chased for 30 min to 18 h. The ratio of labeled
P120 to F80 did not vary with the various pro-
tocols, and thus no precursor-product relation-
ship could be detected.
Because F80 could be found in extracts of
fibroblasts but not lymphoid cells, we asked
whether cleavage of P120 to F80 could have
been due to the presence of a fibroblast-specific
protease. To investigate this, we labeled 2M3
and ANN-1 cells separately with [3S]methio-
nine, and one-half of the labeled cells of each
line were mixed with unlabeled cells from the
other cell line. All four cell samples were broken
at 40C by Dounce homogenization, and the ex-
tracts were left at 40C for 20 min before solubil-
ization and immunoprecipitation. 2M3 cells ex-
tracted alone showed the presence of only P120
(Fig. 5, lane 2), whereas 2M3 cells extracted in
the presence of unlabeled ANN-1 cells showed
the presence of an F80 band (Fig. 5, lane 3); the
mixture had a pattern very similar to the pattern
of labeled ANN-1 cells (Fig. 5, lane 6). Thus,
fibroblasts but not lymphoid cells appeared to
contain a protease which cleaved P120 at a
specific site to generate F80.
In sit;u kinase assay. Because kinase activity
was demonstrable readily in immunoprecipitates
from the solubilized DIM fraction, we investi-
gated the kinase activity of the DIM fraction
itself. Cells were extracted, and the DIM fraction
was incubated in situ with [-y-32P]ATP. The in
situ kinase assay was performed originally by
incubation in 20mM Tris (pH 8.0) containing 10
mM MnCl2 because these conditions were opti-
mal for phosphorylation of P120 in the in vitro
kinase assay (25). In the in situ system, however,
we found that equivalent results were obtained
if the DIM fraction was incubated directly in
extraction buffer. We continued to use these
latter conditions for optimal preservation of the
DIM fraction structure. After the reaction, the
DIM fraction was solubilized and immunopre-
cipitated with anti-M-MuLV serum. ANN-1
cells yielded a prominent F80 band, a weak P120
band, and an additional band having a molecular
weight of about 100,000 (Fig. 6, lane 1). Another
cell line that made a P120 protein (A2) also
produced labeled P120 and F80 (Fig. 6, lane 4).
We examined cells transformed by A-MuLV
strains that made different sizes of Abelson pro-
teins in the same way. A cell line transformed
by A-MuLV(P90) gave rise to a weakly labeled
P90 band plus a strong band of F80 (Fig. 6, lane
2). A-MuLV(P160) gave rise to a labeled P160
band and three other bands, all of which were
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larger than F80 (Fig. 6, lane 3). The 90,000-
molecular-weight band was the most intense; it
may be homologous to the F80 produced by the
P120 strains.
In situ labeling oflymphoid cell DIM fractions
from 2M3 and 2M3/M cells, both transfonned
by A-MuLV(P120), gave rise almost exclusively
to radioactive P120 (Fig. 6, lanes 5 and 6). This
again emphasized that the protease which cut
F80 from P120 was not present in lymphoid cell
extracts.
To determine what proportion of the 'PO4
incorporated by the DIM fraction was found in
A-MuLV proteins, we examined the fraction
without immunoprecipitation (Fig. 6, lanes 7
through 15). Uninfected NIH/3T3 cells con-
tained a number of labeled proteins, but none
was very prominent (Fig. 6, lane 11). Infected
fibroblast cells produced a number of common
bands, which sometimes also appeared in unin-
fected cells and were of unknown significance.
More importantly, the F80 fragment and the
F90 fragment from A-MuLV(P160) were clearly
evident, showing that these compounds were
major products of the in situ kinase assay. In
contrast, the in vivo-labeled A-MuLV phospho-
protein could not be distinguished without im-
munoprecipitation (unpublished data).
Extracts of lymphoid cells that were not im-
munoprecipitated produced much heavier bands
of labeled A-MuLV proteins than fibroblasts,
and they were also largely undegraded (Fig. 6,
lanes 12 through 14). Cell line 2M3 and an
equivalent cell line, 18-81, produced P120 as
their most prominent in situ-labeled band (Fig.
6, lanes 12 and 13). Cell line 18-48 produced a
prominent P100 band (lane 14); its A-MuLV had
been shown previously to synthesize P100 (7a).
As a control, chemically transformed 70Z cells
were labeled in situ, and they were shown to
lack any prominent labeled band (lane 15).
To identify the amino acid phosphorylated in
the in situ reactions, the A-MuLV proteins la-
beled in situ were collected by immunoprecipi-
tation with an anti-M-MuLV serum and sub-
jected to partial acid hydrolysis. The combina-
tion ofP120 and F80 contained exclusively phos-
phorylated tyrosine residues when it was labeled
in the presence of Mn2" (Fig. 7, lane 2) and at
most a hint ofphosphoserine when it was labeled
in the presence of Mg2e (Fig. 7, -lane 1). In
contrast, the total DIM fraction showed exten-
sive labeling of serine residues (Fig. 7, lane 3).
These experiments showed that the in situ
activity of the A-MuLV-associated tyrosine ki-
nase activity is the most prominent activity in
DIM fractions from transformed lymphoid cells
and is also an easily detected activity in trans-
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FIG. 5. Effect of mixing 2M(3 and ANN-1 cell ex-
tracts. ANN-1 and 2M(3 cells were labeled separately
with [TMSJmethionine for 1.5 h. After labeling, the
cells were collected by centrifitgation and suspended
in cold phosphate-buffered saline. Labeled and un-
labeled cells were mixed as indicated below and were
allowed to sweUl for 10 min at 4°C in 10mM Tris (pH
7.4)-i mMMgCl2 before being homogenized. The cell
extracts were left for 20 min at 4°C before solubili-
zation in lysis buffer and immunoprecipitation.
Lanes 1, 4, and 5, labeled 2M3 cell extract, labeled
2M3 cell extract plus unlabeled ANN-I ceU extract,
and labeled ANN-1 cell extract, respectively, all im-
munoprecipitated with normal goat serum; lanes 2,
3, and 6, labeled 2M3 cell extract, labeled 2M3 cell
extract plus unlabeled ANN-1 cell extract, and la-
beled ANN-1 cell extract, respectively, all immuno-
precipitated with goat anti-M-MuLV serum.
formed fibroblast cells. This is in marked con-
trast to results obtained with cells labeled in
culture with 'PO4, where the A-MuLV proteins
are not major bands and most of the P04 in the
A-MuLV protein is on serine residues (25).
DISCUSSION
It has been shown previously that pp6O0 is
associated with a DIM fraction in Rous sarcoma
virus-transformed chicken embryo fibroblasts
(3). In this paper we show that the A-MuLV
P120-associated kinase activity is also located
mainly in the DIM fraction of both transformed
fibroblast and lymphoid cells. Unlike 'PO4-la-
beled pp60, however, the P120 distribution, as
measured by 'PO4- or 3S-labeled protein, was
not the same as the distribution of enzyme ac-
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FIG. 6. In situ protein kinase assay of different cell lines. Cells were allowed to attach to dishes coated
withpoy-L -lysine and were fractionated with extraction buffer into DIM andSOL fractions. The SOL fraction
was removed, and the DIM fraction was incubated with 200 ,ul of extraction buffer containing 50 uCi of [y-32PJATP for 2 min at 4°C. The DIM fraction was then solubilized and subjected to sodium lauryl sulfate
polyacrylamide gel electrophoresis. Lanes 1 through 6 contained samples which were immunoprecipitated
with goat anti-M-MuLV serum. Lane 1, ANN-1 cells; lane 2, P9OB-3 cells; lane 3, P160N54 cells; lane 4, A2
cells; lane 5, 2M3 cells; lane 6, 2M3/M cells. Lanes 7 through 15 contained samples which were notimmunoprecipitated. Lane 7, ANN-1 cells; lane 8, A2 cells; lane 9, P160N54 cells; lane 10, P9OB-3 cells; lane11, NIH/3T3 cells; lane 12, 2M3 cells; lane 13, 18-81 cells; lane 14, 18-48 cells; lane 15, 70Z cells.
tivity. In 2M3 cells, a short labeling period did
produce a distribution equivalent to the enzyme
activity distribution, but after a longer labeling
period equal amounts of P120 were found in the
DIM and SOL fractions. Similarly, briefly la-
beled ANN-1 cells showed equal amounts of
P120 in both fractions, but after longer labeling
most of the P120 was found in the SOL fraction.
Thus, in both lymphoid and fibroblast cells, we
found an apparent movement of P120 from the
DIM fraction to the SOL fraction. It is possible
that newly synthesized P120 is located in the
DIM fraction and is enzymatically active and
that it then moves to the SOL fraction, losing
enzymatic activity. It is also possible that the
kinase activity in immunoprecipitates of P120 is
due to an associated protein which is not bound
to the form of P120 found in the SOL fraction.
The P120-associated kinase activity purifies
with P120 through a number ofchromatographic
purification steps (A. Dasgupta and D. Balti-
more, unpublished data), but it has not been
shown rigorously that P120 is itself a kinase.
An 80,000-molecular-weight protein (F80) an-
tigenically related to P120 was identified previ-
ously (15). F80 showed a different distribution
profile than P120; it was always recovered pre-
dominantly with the DIM fraction. We found
that F80 is a cleavage product of P120 and
contains the gag portion of the molecule. F80
also contains many, if not most, of the sites
phosphorylated by the P120-associated kinase,
but it is not known whether F80 is itself a kinase.
Witte et al. (26a) have shown that most of the
phosphorylatable sites on P120 are located in
the amino-terminal 43,000 daltons ofthe protein;
thus, the presence of phosphorylatable sites in
F80 would be expected. Although fibroblast cell
extracts were capable of cleaving P120 in a
lymphoid cell extract, we do not know whether
any cleavage of P120 to F80 occurs in vivo in
fibroblasts. Our failure to chase P120 to F80
suggests that some cleavage may occur during
experimental manipulations, but both in vivo
and experimentally induced cleavages may oc-
cur.
Most of the F80 is recovered in the DIM
fraction whether the protein is labeled in vitro
or in vivo. It is difficult to know whether this
means that P120 is most susceptible to cleavage
J.- VIROL.
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FIG. 7. Characterization of the phosphoamino
acids after in situ protein kinase assay. ANN-I cells
were fractionated with extraction buffer into DIM
and SOL fractions. The SOL fraction was removed,
and the DIM fraction was incubated with 50 ,iCi of
[y-32P]ATP in situ at 4°Cfor2 min. TheDIMfraction
was solubilized in lysis buffer, clarified by ultracen-
trifugation, and immunoprecipitated with goat anti-
M-MuLVserum. Samples containing about 5,000 cpm
were hydrolyzed in 6 NHC at 100°C for 2 h, applied
to Whatman 3MM paper, and subjected to electro-
phoresis in pyridine acetic acid buffer (pH 3.5) at
2,400 V for 1 h. Each of the hydrolyzed samples was
mixed with unlabeled phosphoserine, phosphothreo-
nine, and phosphotyrosine markers, and the electro-
phoresis paper was stained with ninhydrin to locate
the markers. Lane 1, DIM fraction reacted in the
presence ofMg2" and immunoprecipitated with goat
anti-M-MuLVserum; lane 2, DIMfraction reacted in
the presence of Mn2" and immunoprecipitated with
goat anti-M-MuLV serum; lane 3, DIM fraction re-
acted in the presence ofMn2+ and analyzed without
immunoprecipitation.
when it is bound or that F80 is bound selectively.
Whatever the interpretation, this result implies
that the F80 portion of P120 probably contains
the binding site for the DIM fraction. F80 retains
the gag determinants of P120, and it could be
the gag determinants that bind it to the DIM
fraction. Perhaps P120 binds less well because
ofcompeting interactions with lipids, detergents,
or other proteins.
These experiments, as well as others (26a),
have provided evidence for the localization of
the A-MuLV protein in transformed cells and
the position of antigenic determinants on the
protein. Because the F80 fragment contains all
of the gag determinants but does not react with
anti-AbT serum, the 40,000-molecular-weight
fragment lost during cleavage must be part of
the Abelson virus-specific region of the protein.
Anti-AbT serum but not anti-gag serum reacts
with determinants on P120 found on the surface
of the cell. Thus, we concluded previously that
some of the P120 is a transmembrane protein
(28). In similar experiments, we have shown that
the P90 protein exhibits much less reactivity
with anti-AbT serum on the cell surface,
whereas P160- and P120-transformed fibroblasts
have similar intensities of surface fluorescence
(unpublished data). Furthernore, absorption of
anti-P120 serum with extracts containing the
P90 protein left antibodies that were reactive
with P120, implying that the serum reacted with
the carboxy-terminal portion of P120, which is
absent in P90 (unpublished data). Like F80, P90
lacks the carboxy-terminal Abelson virus-spe-
cific sequence found in P120. These results are
consistent with the hypothesis that a majority
of the anti-AbT-reactive determinants are on
the cell surface and that these constitute the
carboxy-terminal portion of the A-MuLV pro-
tein. This region is lost either by protease frag-
mentation to generate F80 or by the mutation
that truncates P120 to generate P90. Figure 8
shows a model for the organization of the P120
and P90 A-MuLV proteins. Because A-
MuLV(P120) transforms both lymphoid and fi-
broblastic cells but A-MuLV(P90) has very little
< F80
-
gag
P90
gag
P120
P92tdA
DIM ASSOCIATION
Plosma
Membrane
FIG. 8. Model for the organization of A-MuLV
proteins. Symbols: E-A-@, antigenic determinants
recognized by anti-AbT serum; A--, those antigenic
determinants present on P120 but not on P90; A,
region deleted in the transformation-defective P92td
strain.
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lymphoid cell-transforming activity compared
with its fibroblast-transforming activity, one im-
plication of this model for the organization of
the proteins is that determinants on the outer
face of the cell may play a role in the lymphoid
cell-transforming ability of the A-MuLV(P120)
strain.
The largest A-MuLV-specific protein is P160,
which is made by A-MuLV(P160) strains of the
virus. This protein did not give rise to F80 in
extracts of transformed fibroblasts but rather
gave rise to a major cleavage product of about
90,000 daltons. Thus, it appears that P160 is
cleaved at a position in the protein which was
deleted in the process of generating P120.
It is interesting that the fractionation proce-
dure used here distinguished quite well between
two apparently different forms of P120. The
form retained by the DIM fraction has associ-
ated catalytic activity in vitro and in situ,
whereas most of the P120 found in the SOL
fraction has little associated catalytic activity.
Without a better understanding of the factors
that control the kinase activity associated with
P120 and without a more complete knowledge
of the interactions that lead proteins to bind to
elements of the DIM fraction, it is difficult to
explain the significance of these observations.
Our results indicate some potentially funda-
mental similarities in the behaviors of A-MuLV
P120 and Rous sarcoma virus pp60', suggesting
a common pathway(s) of transformation for the
two viruses, which may involve interactions with
both the plasma membrane of the cell and the
subcellular DIM fraction.
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